Health-care companies fell, but not by as some sectors, as traders rotated into sectors that are less sensitive to shifts in Federal Reserve policy.

KemPharm shares fell after the drug developer exchanged stock warrants for 6.1 million common shares.

A Brussels court ruled that British drug maker AstraZeneca isn't required to accelerate deliveries of its Covid-19 vaccine to the European Union and is not on the hook for big fines the bloc had sought to impose in a lawsuit over delivery delays.


 Write to Rob Curran at rob.curran@dowjones.com 

(END) Dow Jones Newswires

06-18-21 1703ET